This strategy is also explored for the treatment of glioblastoma as the Tf receptor is abundantly distributed in glioblastoma and blood−brain barrier cells, and many studies have developed transferrin-modified nanosystems for glioblastoma therapy [139]. Here, TF is linked to glioblastoma.